CHINA SPEEDS HEALTH REFORM TO CUT COSTS

7 March 1994

China is to speed up ongoing reform of its health care system in 1994 with the aim of sharing the cost of health care provision "rationally" between the government, enterprises and individuals, according to a Labor Ministry report on the introduction of a new social service system in China.

Labor Ministry sources say that changes will include establishing a health care insurance fund to cover the costs of serious diseases and setting up medical care accounts which will pool the money from part of the raised salaries of workers. The reforms will be tested in key cities and, according to an official from the National Center for Medical Insurance, they will not lower the level of health care of urban dwellers.

Liu Xiufeng, deputy director at the Center, says that the Chinese free health service, now over 40 years old, has played an important role in protecting health, promoting economic development and maintaining social stability. However, it had the disadvantages of excessive use of expensive medicines and the "indiscriminate waste of money."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight